Yakulink participated alongside Hedinger at Interphex Japan 2025, showcasing our high-quality excipients to leading professionals in the Japanese biopharmaceutical industry. It was a great opportunity to strengthen existing partnerships, introduce our portfolio to new clients, and demonstrate our commitment to quality, reliability, and international collaboration.

Yakulink Co., Ltd. has officially been established in Tokyo, Japan, marking a new chapter in cross-border pharmaceutical trade. Founded by industry veterans, Yakulink is set to provide high-quality biopharmaceutical excipients and technical support to partners across Japan, Korea, China, and Europe. With strong roots and a global outlook, the company…